Chicago Pacific Founders UGP III, LLC - Sep 4, 2024 Form 4 Insider Report for P3 Health Partners Inc. (PIII)

Role
10%+ Owner
Signature
Chicago Pacific Founders UGP III, LLC, /s/ Michael J. Wilson, authorized signatory
Stock symbol
PIII
Transactions as of
Sep 4, 2024
Transactions value $
$117,544
Form type
4
Date filed
9/11/2024, 06:17 AM
Previous filing
Oct 4, 2023
Next filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIII Class A Common Stock Purchase $39.1K +80K +0.1% $0.49 76.6M Sep 4, 2024 See Footnote F1, F2
transaction PIII Class A Common Stock Purchase $39.3K +80K +0.1% $0.49 76.7M Sep 5, 2024 See Footnote F2, F3
transaction PIII Class A Common Stock Purchase $39.2K +80K +0.1% $0.49 76.8M Sep 6, 2024 See Footnote F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.47 to $0.50. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F2 Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.48 to $0.52. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.47 to $0.51. The reporting person undertakes to provide P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.